FDA Drug Recalls

Recalls / Class III

Class IIID-1677-2012

Product

Pramipexole Dihydrochloride Tablets, 0.25 mg, 90-count tablets per bottle, Rx only, Manufactured in India by Sandoz Private Ltd., for Sandoz Inc., Princeton, NJ 08540, NDC 0781- 5249-92,

Affected lot / code info
Lot numbers: BJ3338; BJ3339; BJ 3340; BJ3341; BJ3342; BJ6282; BJ7192; BM8498; BJ7202; BJ7203, Exp 12/12

Why it was recalled

Impurities/Degradation Products: An out of specification result for a known impurity of the product occurred during 12 month stability testing.

Recalling firm

Firm
Sandoz Incorporated
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2555 W Midway Blvd, Broomfield, Colorado 80020-1632

Distribution

Quantity
43,060 x 90 count bottles
Distribution pattern
Nationwide

Timeline

Recall initiated
2012-09-12
FDA classified
2012-09-19
Posted by FDA
2012-09-26
Terminated
2013-04-10
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1677-2012. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.